
Freedom Capital lowered the firm’s price target on Inspire Medical (INSP) to $93 from $97 and keeps a Buy rating on the shares. Shares are down about 10% since reporting
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| INSP | Inspire Medical Systems | 61.10 | -25.25 | -29.24% |
| Name | Price | % Change | |
|---|---|---|---|
| $61.10 | -29.24% |

Freedom Capital lowered the firm’s price target on Inspire Medical (INSP) to $93 from $97 and keeps a Buy rating on the shares. Shares are down about 10% since reporting

UBS raised the firm’s price target on Inspire Medical (INSP) to $45 from $40 and keeps a Sell rating on the shares. Published first on TheFly – the ultimate source

Inspire Medical (($INSP)) has held its Q3 earnings call. Read on for the main highlights of the call. Inspire Medical delivered a cautiously optimistic earnings call as third-quarter revenue fell

JPMorgan analyst Robbie Marcus raised the firm’s price target on Inspire Medical (INSP) to $65 from $60 and keeps a Neutral rating on the shares. Published first on TheFly –

Piper Sandler raised the firm’s price target on Inspire Medical (INSP) to $70 from $60 and keeps a Neutral rating on the shares. The firm notes the company reported a

Wells Fargo raised the firm’s price target on Inspire Medical (INSP) to $69 from $56 and keeps an Equal Weight rating on the shares. The firm notes the company reported

Baird raised the firm’s price target on Inspire Medical (INSP) to $77 from $73 and keeps a Neutral rating on the shares. The firm updated its model following it Q3

Barclays lowered the firm’s price target on Inspire Medical (INSP) to $62 from $65 and keeps an Underweight rating on the shares. The firm says the company’s Q3 beat reduced

The latest update is out from Inspire Medical Systems ( ($INSP) ). On November 2, 2026, Inspire reported third-quarter revenue of $206.7 million, down 7.9% from a year earlier, as

Reports Q3 revenue $206.695M, consensus $204.31M. “We are pleased to have delivered sequential growth in the third quarter, with U.S. performance coming in ahead of our expectations. Results suggest that,
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| sell | Reiterated | Nov 6, 2026 | ||||
| hold | Reiterated | Nov 3, 2026 | ||||
| hold | Assigned | Nov 3, 2026 | ||||
| buy | Reiterated | Nov 3, 2026 | ||||
| sell | Reiterated | Nov 3, 2026 | ||||
| buy | Reiterated | Nov 3, 2026 | ||||
| hold | Reiterated | Nov 3, 2026 | ||||
| hold | Reiterated | Nov 3, 2026 | ||||
| hold | Reiterated | Nov 2, 2026 | ||||
| hold | Reiterated | Nov 2, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 9, 2027TBA | $1.75B | $0.92 | $243.66M | 0.11 | 17.55 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.